Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

62671 Press Releases
DateTitleCompany
06 Sep 11 Research and Markets: Auto Inflammatory Disease - Pipeline Review, Q2 2011 Research and Markets,
Published by
Business Wire
06 Sep 11 Rib-X Pharmaceuticals Named a 2011 Fierce 15 Company by FierceBiotech Rib-X Pharmaceuticals Inc.,
Published by
Business Wire
06 Sep 11 Biogen Idec Fully Acquires Biogen Dompé Joint Ventures Biogen Idec,
Published by
Business Wire
06 Sep 11 Research and Markets: Essential Thrombocythemia - Pipeline Review, Q3 2011 Research and Markets,
Published by
Business Wire
06 Sep 11 Research and Markets: West Nile Virus Infections - Pipeline Review, Q2 2011 Research and Markets,
Published by
Business Wire
06 Sep 11 Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12 Anika Therapeutics Inc.,
Published by
Business Wire
06 Sep 11 Synta to Present at the Rodman & Renshaw Annual Global Investment Conference Synta Pharmaceuticals Corp.,
Published by
Business Wire
06 Sep 11 Research and Markets: Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, Q2 2011 Research and Markets,
Published by
Business Wire
06 Sep 11 Theraclone Sciences Named a 2011 Fierce 15 Biotech by FierceBiotech Theraclone Sciences,
Published by
Business Wire
06 Sep 11 Pfizer Announces Successful Completion of Initial Cash Tender Offer for Outstanding Shares of Icagen, Inc. and Commencement of Subsequent Offering Period Pfizer Inc.,
Published by
Business Wire
06 Sep 11 Rexahn Pharmaceuticals Announces US Patent Issued for CNS-based Treatment of Sexual Dysfunction Rexahn Pharmaceuticals Inc.,
Published by
Business Wire
06 Sep 11 Maven Semantic: Transporter Protein Research Database Maven Semantic,
Published by
Business Wire
06 Sep 11 Sanofi Video Q&A: CEO Chris Viehbacher Comments on Key Messages from the Investor Relations Seminar Sanofi,
Published by
Business Wire
06 Sep 11 Walgreens August Sales Increase 7.8 Percent Walgreens,
Published by
Business Wire
06 Sep 11 Synageva BioPharma Announces Appointment of Leading Clinician and Rare Disease Pioneer as Senior Vice President of Product Development Synageva BioPharma Corp.,
Published by
Business Wire
06 Sep 11 AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New York AmpliPhi Biosciences Corporation,
Published by
Business Wire
06 Sep 11 Anacor and GlaxoSmithKline Amend and Expand R&D Collaboration Anacor Pharmaceuticals,
Published by
Business Wire
06 Sep 11 BioTime Enters into Worldwide License Agreement with Cornell University to Develop and Commercialize Vascular Cells Derived from Human Embryonic Stem Cells BioTime Inc.,
Published by
Business Wire
06 Sep 11 Impax Laboratories Appoints Carole Ben-Maimon, M.D. President of Global Pharmaceuticals Impax Laboratories Inc.,
Published by
Business Wire
06 Sep 11 ARIAD Announces Appointment of Senior Pharmaceutical Executive to Lead Global Commercial Operations ARIAD Pharmaceuticals Inc.,
Published by
Business Wire
06 Sep 11 TESARO Named as a 2011 Fierce 15 Biotech Company TESARO Inc.,
Published by
Business Wire
06 Sep 11 RainDance Technologies to Update Investment Community on Recent Milestones and Growth Strategy at UBS and Stifel Nicolaus Conferences RainDance Technologies Inc.,
Published by
Business Wire
06 Sep 11 Phase 2a Study of Selective Oral JAK3 Inhibitor VX-509 Showed Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
06 Sep 11 NanoViricides Selects Its First FluCide™ Clinical Candidate For FDA Submission NanoViricides Inc.,
Published by
Business Wire
06 Sep 11 AmerisourceBergen Acquires IntrinsiQ, LLC AmerisourceBergen Corporation,
Published by
Business Wire
06 Sep 11 CytRx to Present at the Rodman & Renshaw 13th Annual Healthcare Conference CytRx Corporation,
Published by
Business Wire
06 Sep 11 Medical Marijuana Inc.'s Marijuana Extract Cannabidiol (CBD) Possible Use As A Prevention And Treatment To Alzheimer’s Disease Medical Marijuana Inc.,
Published by
Business Wire
06 Sep 11 CorMedix Announces Amended Agreement for CRMD001 (A Proprietary Formulation of Deferiprone) CorMedix Inc.,
Published by
Business Wire
06 Sep 11 FORMA Therapeutics Named by FierceBiotech in the 2011 Fierce 15 FORMA Therapeutics,
Published by
Business Wire
06 Sep 11 Blueprint Medicines Named One of FierceBiotech’s “Fierce 15” Leading Biotech Companies of 2011 Blueprint Medicines,
Published by
Business Wire
Advertising